Pay-for-performance incentives in the United Kingdom have not helped improve patients’ diabetes care, and the incentives may have led to reduced care for some diabetics, according to a study in the British Medical Journal. Modern Healthcare writes that Britain’s pay-for-performance program for all primary-care physicians, launched in 2004, is closely watched in the United States as a possible model to incentivize physicians to reduce costs and improve quality.
Researchers looked at the proportion of patients meeting diabetes-care targets—including controlling glucose, blood pressure and cholesterol—between 2001 and 2007, before and after the nation’s pay-for-performance program began. The researchers found improvements in diabetes care and treatment, but these seemed to plateau after 2004, when the incentives kicked in.
Read full article: P4P not helping diabetic care in U.K.: study, Modern Healthcare